Immune response in progressive multifocal leukoencephalopathy: An overview

References

• Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopahty. AIDS 12: 1149–1154.
   PubMed Web of Science ®Google Scholar
• Astrom K-E, Mancall EL, Richardson EP (1958). Pro-gressive multifocal leukoencephalopathy. A hith-erto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81: 93–111.
   Google Scholar
• Baldeweg T, CatalanJ (1997). Remission of progressive mul-tifocal leucoencephalopathy after antiretroviral therapy. Lancet 349: 1554–1555.
   Google Scholar
• Baqi M, Kucharczyk W, Walmsley SL (1997). Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy. AIDS 11: 1526–1527.
   PubMed Web of Science ®Google Scholar
• Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987). Progressive multifoc al leukoencephalopathy associated with human immunodeficiency virus infection. A re-view of the literature with a report of sixteen cases. Ann intern Med 107: 78–87.
   Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predic-tive factors for prolonged survival in acquired immuno-deficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Berner B, Krieter DH, Rumpf KW, Grunewald RW, Beuche W, Weber T, et al (1999). Progressive multi-focal leukoencephalopathy in a renal transplant pa-tient diagnosed by JCV-specific DNA amplification and an intrathecal humoral immune response to recombi-nant virus protein 1. Nephrol Dial Transplant 14: 462–465.
   Google Scholar
• Budka H, Shah KV (1983). Papovavirus antigens in paraffin sections of PML brains. Prog Clin Biol Res 105: 299–309.
   Google Scholar
• De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and vi-rological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progres-sive multifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.
   PubMed Web of Science ®Google Scholar
• Domingo P, Guardiola JM, Iranzo A, Margall N (1997). Remission of progressive multifocal leucoencephalopa-thy after antiretroviral therapy. Lancet 349: 1554–1555.
   Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progres-sive multifocal leukoencephalopathy: improved sur-vival of human immunodeficiency virus-infected pa-tients in the protease inhibitor era. I Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Eggers C, Stellbrink HJ, Buhk T, Dorries K (1999). Quantifi-cation of JC virus DNA in the cerebrospinal fluid of pa-tients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy-a longi-tudinal study. I Infect Dis 180: 1690–1694.
   Google Scholar
• Elliot B, Aromin I, Gold R, Flanigan T, Mileno M (1997). 2.5 year remission of AIDS-associated progressive multifo-cal leukoencephalopathy with combined antiretroviral therapy. Lancet 349: 850.
   Google Scholar
• Ellison GW (1969). Progressive multifocal leukoen-cephalopathy (PML). I. Investigation of the immunologic status of a patient with lymphosarcoma and PML. I Neu-ropathol Exp Neurol 28: 501–506.
   Google Scholar
• Frye S, Trebst C, Dittmer U, Petry H, Bodemer M, Hunsmann G, Weber T, Liike W (1997). Efficient pro-duction of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cel-lular immune response. I Virol Methods 63: 81–92.
   Google Scholar
• Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999). Pro-longed survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretrovi-ral therapy. J NeuroVirol 5: 421–429.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, et al (2000). Highly active antiretroviral ther-apy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus repli-cation and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Goldmann C, Petry H, Frye S, Ast O, Ebitsch S, Jentsch KD, et al (1999). Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for im-munological and therapeutic studies. I Virol 73: 4465–4469.
   PubMed Web of Science ®Google Scholar
• Guillaume B, Sindic CJ, Weber T (2000). Progressive mul-tifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid. Eur J Neurol 7: 101–106.
   Google Scholar
• Inui K, Miyagawa H, Sashihara J, Miyoshi H, Tanaka-Taya K, Nishigaki T, et al (1999). Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain Dev 21: 416–419.
   PubMedGoogle Scholar
• Katz DA, Berger JR, Hamilton B, Major EO, Post MJ (1994). Progressive multifocal leukoencephalopathy complicat-ing Wiskott-Aldrich syndrome. Report of a case and re-view of the literature of progressive multifocal leukoen-cephalopathy with other inherited immunodeficiency states. Arch Neurol 51: 422–426.
   Google Scholar
• Knight A, O'Brien P, Osoba D (1972). "Spontaneous" pro-gressive multifoc al leukoencephalopathy. Immunologic aspects. Ann Intern Med 77: 229–233.
   Google Scholar
• Knowles WA, Luxton RW, Hand JF, Gardner SD, Brown DWG (1995). The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leu-coencephalopathy. Clin Diag Virol 4: 183–194.
   Google Scholar
• Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999). JC virus DNA load in patients with and without pro-gressive multifocal leukoencephalopathy. Neurology 52: 253–260.
   Google Scholar
• Koralnik 1J, Du Pasquier R, Pfister L-A, Letvin NL (2000). JC virus-specific cytotoxic T lymphocytes in patients with AIDS-associated progressive multifocal leukoen-cephalopathy. Neurology 753: A173.
   Google Scholar
• Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T (1993). Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract 189: 163–173.
   Google Scholar
• Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of pro-gressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.
   PubMed Web of Science ®Google Scholar
• Major EO, Ault GS (1995). Progressive multifocal leukoen-cephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunode-ficient patient. Curr Opin Neurol 8: 184–190.
   Google Scholar
• Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.
   PubMed Web of Science ®Google Scholar
• Monno L, Zimatore GB, Di Stefano M, Appice A, Livrea P, Angarano G (1999). Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy. I Neurol Neurosurg Psychiatry 67: 369–373.
   Google Scholar
• Owen RG, Patm ore RD, Smith GM, Barnard DL (1995). Cytomegalovirus-induced T-cell prolifera-tion and the development of progressive multifocal leucoencephalopathy following bone marrow trans-plantation. Br J Haematol 89: 196–198.
   Google Scholar
• Padgett BL, Walker DL (1973). Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 127: 467–470.
   PubMed Web of Science ®Google Scholar
• Padgett BL, Walker DL (1976). New human papovaviruses. Prog Med Virol 22: 1–35.
   PubMedGoogle Scholar
• Padgett BL, Walker DL (1983). Virologic and serologic stud-ies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res 105: 107–117.
   PubMedGoogle Scholar
• Padgett BL, Walker DL, ZuRhein GM, Hodach AE, Chou SM (1976). JC Papovavirus in progressive multifocal leukoencephalopathy. I Infect Dis 133: 686–690.
   PubMed Web of Science ®Google Scholar
• Peters AC, Versteeg J, Bots GT, Boogerd W, Vielvoye GJ (1980). Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 37: 497–501.
   Google Scholar
• Power C, Nath A, Aoki FY, Bigio MD (1997). Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J. Med 336: 661–662.
   Google Scholar
• Reiber H, Felgenhauer K (1987). Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central ner-vous system. Clin Chim Acta 163: 319–328.
   PubMed Web of Science ®Google Scholar
• Reiber H, Lange P (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37: 1153–1160.
   PubMed Web of Science ®Google Scholar
• Richardson EPJ (1961). Progressive multifocal leukoen-cephalopathy. N Engl J. Med 265: 815–823.
   PubMed Web of Science ®Google Scholar
• Rockwell D, Ruben FL, Winkelstein A, Mendelow H (1976). Absence of imune deficiencies in a case of progressive multifocal leukoencephalopathy. Am I Med 61: 433–436.
   Google Scholar
• Sindic CJ, Monteyne P, Laterre EC (1994). The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. I Neuroimmunol 54: 75–80.
   PubMed Web of Science ®Google Scholar
• Sindic CJ, Trebst C, Van Antwerpen MP, Frye S, Enzensberger W, Hunsmann G, et al (1997). Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J Neuroimmunol 76: 100–104.
   PubMed Web of Science ®Google Scholar
• Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1999). Progressive multifocal leukoen-cephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
   PubMedGoogle Scholar
• Taoufik Y, Delfraissy JF, Gasnault J (2000). Highly active antiretroviral therapy does not improve survival of pa-tients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagno-sis. AIDS 14: 758–759.
   PubMed Web of Science ®Google Scholar
• Teofilo E, Gouveia J, Brotas V, da Costa P (1998). Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy. AIDS 12: 449.
   Google Scholar
• Walker DL (1985). Progressive multifocal leukoen-cephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, (eds). Handbook of clinical neurology, demyelinating diseases, Vol 47 (3). Amsterdam: Elsevier Science Pub-lishers, pp 503–524.
   Google Scholar
• Weber T, Freter A, Luer W, Haas J, Stark E, Poser S, et al (1991). The use of recombinant antigens in ELISA pro-cedures for the quantification of intrathec ally produced HIV-1-specific antibodies. J Immunol Methods 136: 133–137.
   Google Scholar
• Weber T, Frye S, Bodemer M, Otto M, Liike W (1996). Clin-ical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous sys-tem. I NeuroVirol 2: 175–190.
   Web of Science ®Google Scholar
• Weber F, Goldmann C, Kramer M, Kaup FJ, Pickhardt M, Young P, et al (2001). Humoral and cellular immune re-sponse in progressive multifocal leukoencephalopathy. Ann Neurol, in press.
   Google Scholar
• Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, et al (1997). Analysis of the systemic and intrathe-cal humoral immune response in progressive mul-tifocal leukoencephalopathy. I Infect Dis 176: 250–254.
   PubMed Web of Science ®Google Scholar
• Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B (1980). Progressive multifocal leukoencephalopa-thy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology 30: 256–262.
   Google Scholar
• Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gray-ell M, Hou J, Clifford JB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to sur-vival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoen-cephalopathy. Ann Neurol 45: 816–821.
   PubMed Web of Science ®Google Scholar